Mendus AB (publ)
STO:IMMU

Watchlist Manager
Mendus AB (publ) Logo
Mendus AB (publ)
STO:IMMU
Watchlist
Price: 5.3 SEK -2.57% Market Closed
Market Cap: 323m SEK

Wall Street
Price Targets

IMMU Price Targets Summary
Mendus AB (publ)

Wall Street analysts forecast IMMU stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMMU is 17.34 SEK with a low forecast of 17.17 SEK and a high forecast of 17.85 SEK.

Lowest
Price Target
17.17 SEK
224% Upside
Average
Price Target
17.34 SEK
227% Upside
Highest
Price Target
17.85 SEK
237% Upside
Mendus AB (publ) Competitors:
Price Targets
688192
Dizal Jiangsu Pharmaceutical Co Ltd
66% Upside
HPHA
Heidelberg Pharma AG
134% Upside
300896
Imeik Technology Development Co Ltd
38% Upside
MNKD
MannKind Corp
60% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
48% Upside
REGN
Regeneron Pharmaceuticals Inc
3% Upside
GBIO
Generation Bio Co
61% Upside
IVVD
Invivyd Inc
178% Upside

Revenue
Forecast

Revenue Estimate
Mendus AB (publ)

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Mendus AB (publ)

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Mendus AB (publ)

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-88%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMMU's stock price target?
Price Target
17.34 SEK

According to Wall Street analysts, the average 1-year price target for IMMU is 17.34 SEK with a low forecast of 17.17 SEK and a high forecast of 17.85 SEK.

Back to Top